# Beijing Applied Biological Technologies Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-applied-biological-technologies-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.x-abt.com
- Total disclosed funding: $7M
- Latest round: Series B (Mar 24, 2020)
- Investors on record: 3

## About

Established in 2010 and based in Beijing, China, Beijing Applied Biological Technologies Co., Ltd. operates as an in vitro diagnostic reagents R&D platform dedicated to providing pathogen detection solutions. It acquired certifications such as ISO9001, ISO13485, and CE certification. In January 2016, Beijing Applied Biological Technologies Co., Ltd. was listed on the New Third Board. In March 2020, it raised CNY 50 million in series B funding led by new investor Bio Venture.

The company mainly provides in vitro diagnostic reagents. It provides clinical diagnostic reagents, scientific research diagnostic reagents, and high-throughput sequencing full-process solutions. The clinical diagnostic reagents include respiratory pathogen detection and fever and rash pathogen detection. The scientific research diagnostic reagents include diarrhoea pathogen detection, encephalitis and vector-borne pathogen detection, animal and drug source identification, and zoonotic pathogen detection. Applied Biological also provides customers with installation, maintenance and after-sales services.

The company generates revenue by providing clinical diagnostic reagents, scientific research diagnostic reagents, high-throughput sequencing full-process solutions, and installation, maintenance and after-sales services.

## Funding rounds

- Series B, Mar 24, 2020, $7M — Zero2IPO Ventures, YuanBio Venture, WanSheng Capital

## Investors

- Zero2IPO Ventures (https://capitalatlas.ai/funds/zero2ipo-ventures) — Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B
- WanSheng Capital — Series B